Pulmonary Hypertension Registry Switzerland
Launched by UNIVERSITY OF ZURICH · Nov 8, 2022
Trial Information
Current as of April 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Pulmonary Hypertension Registry Switzerland is a study aimed at understanding pulmonary hypertension, a condition that affects the blood vessels in the lungs, making it hard for the heart to pump blood. This registry collects information from patients in Switzerland who have been diagnosed with pulmonary hypertension and have agreed to share their health data for research purposes. The goal is to gather valuable insights that can help improve treatments and care for people with this condition.
Anyone diagnosed with pulmonary hypertension can be eligible to participate in this registry, regardless of age or gender. If you choose to participate, you will help researchers by providing information about your health and treatment experiences. This study is currently recruiting participants, so if you or someone you know has pulmonary hypertension and is interested, it could be a great opportunity to contribute to important research that may benefit others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with PH
- Exclusion Criteria:
- • -
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Trial Officials
Silvia Ulrich, Prof. Dr.
Principal Investigator
UniversityHospital Zurich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials